- Home
- APLT vs RFIL Comparison
APLT vs RFIL Comparison
Compare APLT & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- RFIL
- Stock Information
- Founded
- APLT 2016
- RFIL 1979
- Country
- APLT United States
- RFIL United States
- Employees
- APLT N/A
- RFIL N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- RFIL Electrical Products
- Sector
- APLT Health Care
- RFIL Technology
- Exchange
- APLT Nasdaq
- RFIL Nasdaq
- Market Cap
- APLT 63.6M
- RFIL 68.7M
- IPO Year
- APLT 2019
- RFIL N/A
- Fundamental
- Price
- APLT $0.42
- RFIL $7.41
- Analyst Decision
- APLT Buy
- RFIL Strong Buy
- Analyst Count
- APLT 6
- RFIL 1
- Target Price
- APLT $6.10
- RFIL $4.50
- AVG Volume (30 Days)
- APLT 883.6K
- RFIL 161.8K
- Earning Date
- APLT 11-06-2025
- RFIL 09-11-2025
- Dividend Yield
- APLT N/A
- RFIL N/A
- EPS Growth
- APLT N/A
- RFIL N/A
- EPS
- APLT N/A
- RFIL N/A
- Revenue
- APLT $121,000.00
- RFIL $76,353,000.00
- Revenue This Year
- APLT N/A
- RFIL $20.11
- Revenue Next Year
- APLT $5,931.24
- RFIL $5.95
- P/E Ratio
- APLT N/A
- RFIL N/A
- Revenue Growth
- APLT N/A
- RFIL 22.60
- 52 Week Low
- APLT $0.30
- RFIL $3.39
- 52 Week High
- APLT $10.62
- RFIL $9.21
- Technical
- Relative Strength Index (RSI)
- APLT 38.92
- RFIL 52.13
- Support Level
- APLT $0.43
- RFIL $6.84
- Resistance Level
- APLT $0.46
- RFIL $8.65
- Average True Range (ATR)
- APLT 0.03
- RFIL 0.64
- MACD
- APLT -0.01
- RFIL 0.11
- Stochastic Oscillator
- APLT 0.35
- RFIL 51.18
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.